Harmony Biosciences Holdings, Inc.
HRMY
$34.10
$1.715.28%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 20.71% | 21.51% | 21.13% | 17.74% | 20.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.71% | 21.51% | 21.13% | 17.74% | 20.62% |
| Cost of Revenue | 30.71% | 26.48% | 26.55% | 23.88% | 26.09% |
| Gross Profit | 17.95% | 20.11% | 19.66% | 16.15% | 19.19% |
| SG&A Expenses | 19.10% | 22.95% | 10.12% | 13.96% | 14.60% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.06% | 25.97% | 18.50% | 15.20% | 32.85% |
| Operating Income | -2.83% | 9.25% | 28.72% | 24.58% | -4.22% |
| Income Before Tax | 0.19% | 12.13% | 31.44% | 36.45% | 5.23% |
| Income Tax Expenses | 16.82% | 21.74% | -15.04% | -11.54% | -10.51% |
| Earnings from Continuing Operations | -4.65% | 9.07% | 51.42% | 57.32% | 10.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.65% | 9.07% | 51.42% | 57.32% | 10.91% |
| EBIT | -2.83% | 9.25% | 28.72% | 24.58% | -4.22% |
| EBITDA | -1.89% | 8.78% | 25.03% | 21.35% | -3.97% |
| EPS Basic | -5.54% | 8.01% | 50.86% | 59.96% | 14.08% |
| Normalized Basic EPS | -0.76% | 10.99% | 30.97% | 31.12% | 2.96% |
| EPS Diluted | -5.23% | 8.10% | 50.85% | 59.14% | 13.50% |
| Normalized Diluted EPS | -0.59% | 10.87% | 30.47% | 30.20% | 2.24% |
| Average Basic Shares Outstanding | 1.05% | 1.07% | 0.29% | -1.30% | -2.92% |
| Average Diluted Shares Outstanding | 0.96% | 1.25% | 0.77% | -0.60% | -2.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |